Jagsonpal Pharmaceuticals Board Meeting April 27

Jagsonpal Pharmaceuticals intimated a board meeting scheduled for April 27, 2026 under SEBI LODR Regulation 29.
The board will consider and approve audited financial results for Q4 and full year FY26 ending March 31, 2026.
The board will also consider recommending dividend for the financial year ended March 31, 2026.